Literature DB >> 7684615

Generation and partial characterization of five monoclonal antibodies with high affinities for fibrin.

P M Tymkewycz1, L J Creighton Kempsford, P J Gaffney.   

Abstract

Five fibrin-specific monoclonal antibodies have been generated using three different immunogens and a unique clot/plasma screening procedure. Two of the mAbs are directed to an epitope(s) on the A alpha-chain of fibrinogen while two others seem to react with a distinct B beta-chain epitope(s). A third antibody seems to displace all the mAbs from fibrin and may be directed to a repeating structural domain in the fibrin. The Kd values obtained (approximately 10(-9)M) using dried fibrin clots suggest high avidity for fibrin. All the mAbs cross-react with the fibrin-like X-oligomer structure in solution but in the presence of fibrin this reaction seems irrelevant due to the low Kd of the mAb/fibrin reaction. These mAbs have been examined for uptake by fibrin in a laboratory circulation circuit and while the uptake was dependent on mAb concentration an increase was noted for most concentrations over the first 2 h of circulation in the presence of plasma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684615     DOI: 10.1097/00001721-199304000-00002

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  3 in total

1.  Targeted PARACEST nanoparticle contrast agent for the detection of fibrin.

Authors:  Patrick M Winter; Kejia Cai; Junjie Chen; Christopher R Adair; Garry E Kiefer; Phillip S Athey; Patrick J Gaffney; Carolyn E Buff; J David Robertson; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Journal:  Magn Reson Med       Date:  2006-12       Impact factor: 4.668

Review 2.  An unmet clinical need: The history of thrombus imaging.

Authors:  Gregory M Lanza; Grace Cui; Anne H Schmieder; Huiying Zhang; John S Allen; Michael J Scott; Todd Williams; Xiaoxia Yang
Journal:  J Nucl Cardiol       Date:  2017-06-12       Impact factor: 5.952

3.  A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke.

Authors:  Jon N Marsh; Grace Hu; Michael J Scott; Huiying Zhang; Matthew J Goette; Patrick J Gaffney; Shelton D Caruthers; Samuel A Wickline; Dana Abendschein; Gregory M Lanza
Journal:  Nanomedicine (Lond)       Date:  2011-04-20       Impact factor: 5.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.